latest news

News / Pharma

What’s a SPAC? A Route to Public Markets for Gemini Therapeutics

Heather Johnson / March 3, 2021
News / Pharma

Ocular Gene Therapy Takes Next Step Beyond Inherited Retinal Disease

News

Verana Health and Janssen Enter Real-World Data and Data Science Collaboration

News / Pharma

With New Clarity of Trial Data, Outlook Therapeutics Stock Rebounds

News

Merge Ahead: Where the Parallel Tracks for Future Innovations in Presbyopia May Meet

Pharmaceuticals & Genetics

What’s a SPAC? A Route to Public Markets for Gemini Therapeutics

March 3, 2021

Ocular Gene Therapy Takes Next Step Beyond Inherited Retinal Disease

February 23, 2021

With New Clarity of Trial Data, Outlook Therapeutics Stock Rebounds

February 10, 2021

Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs

August 18, 2020

Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary

August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

July 9, 2020

devices & diagnostics

Emerging Glaucoma Devices See Beyond IOP

Emerging Glaucoma Devices See Beyond IOP

May 27, 2020
Soft CL slows myopia in children

Soft CL slows myopia in children

January 22, 2020
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

September 18, 2019
Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

August 28, 2019
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20, 2019

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Ophthalmic Innovation To Your Inbox.
!
!
!
SUBSCRIBE

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

Subscribe To OIS News

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
!
!
!
Subscribe

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

next ois event

about ois

The OIS programs are presented annually by Healthegy, Inc.

Learn more about our world-class conferences.

Listen To The Podcast

OIS PODCAST 270 [ KOL Perspective] - Thumbnail

KOLs Speak Out on the Future of Gene Therapy

March 3, 2021
OIS Podcast
OIS PODCAST - [ Vince Anido ] - Thumbnail

Sky’s the Limit with the Venerable Dr. Vicente Anido, Jr.

February 24, 2021
OIS Podcast
OIS PODCAST - [ Calvin Roberts ] - Thumbnail

Dr. Cal Roberts Latest Leap to Lighthouse Guild

February 16, 2021
OIS Podcast
OIS PODCAST - [ Robert Dampsey ] - Thumbnail

A Vision of TearClear’s Future with CEO Robert Dempsey

February 10, 2021
OIS Podcast
OIS PODCAST 266 - [ Kim Brazzell ] - Thumbnail

Clearing Regulatory Hurdles with Dr. Kim Brazzell

February 2, 2021
OIS Podcast
OIS PODCAST 265 - [ Shervin Korangy ] - Thumbnail

BVI’s Shervin Korangy

January 26, 2021
OIS Podcast

Deals

OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

July 9, 2020
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10, 2020
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20, 2020
Covid-19 Impact on Healthcare Company Valuations & Financings

Covid-19 Impact on Healthcare Company Valuations & Financings

April 22, 2020
OIS Index: No Immunity to Coronavirus Selloff

OIS Index: No Immunity to Coronavirus Selloff

April 8, 2020

watch videos from ois tv

OIS Index

OIS Index Rallies Back from COVID-Driven Decline

OIS Index Posts a Strong Finish to 2019

OIS Index Outperforms

OIS Index on Positive Upswing

OIS Index Deep in Bear Territory in Q3

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

@oistweets